1. Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.
- Author
-
Yoon, Jiyeon, Ko, Young San, Cho, Sung Jin, Park, Jinju, Choi, Young Sun, Choi, Yiseul, Pyo, Jung‐Soo, Ye, Sang‐Kyu, Youn, Hong‐Duk, Lee, Jae‐Seon, Chang, Mee Soo, Kim, Min A, and Lee, Byung Lan
- Subjects
STOMACH cancer ,CANCER cells ,CELLULAR signal transduction ,METASTASIS ,TRANSCRIPTION factors ,CELL culture - Abstract
The transcription factor signal transducers and activators of transcription 3 ( STAT3) can promote cancer metastasis, but its underlying regulatory mechanisms in gastric cancer cell invasiveness still remain obscure. We investigated the relationship between STAT3 and glycogen synthase kinase-3β ( GSK-3β) and its significance in metastatic potential in gastric cancer cells. Immunohistochemical tissue array analysis of 267 human gastric carcinoma specimens showed that the expressions of active forms of STAT3 ( pSTAT3) and GSK-3β ( pGSK-3β) were found in 68 (25%) and 124 (46%) of 267 gastric cancer cases, respectively, showing a positive correlation (p < 0.001). Cell culture experiments using gastric cancer cell lines SNU-638 and SNU-668 revealed that STAT3 suppression did not affect pGSK-3β expression, whereas GSK-3β inhibition reduced pSTAT3 expression. With respect to metastatic potential in gastric cancer cells, both STAT3 suppression and GSK-3β inhibition decreased cell migration, invasion, and mesenchymal marker (Snail, Vimentin, and MMP9) expression. Moreover, the inhibitory effects of STAT3 and GSK-3β on cell migration were synergistic. These results demonstrated that STAT3 and GSK-3β are positively associated and synergistically contribute to metastatic potential in gastric cancer cells. Thus, dual use of STAT3 and GSK-3β inhibitors may enhance the efficacy of the anti-metastatic treatment of gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF